[ FROM THE FIELD ]
2020 AMERICAN SOCIETY OF HEMATOLOGY MEETING UPDATES The Lymphoma Research Foundation (LRF) returned to the American Society of Hematology (ASH) Annual Meeting and Exposition with nearly 70 LRF-affiliated scientists, including past and present members of LRF’s world-leading Scientific Advisory Board (SAB) and grantees, presenting abstracts at the virtual conference. Widely regarded as the premier event in malignant and non-malignant hematology, the ASH Meeting, held virtually from December 5-8, 2020, due to the COVID-19 pandemic, provided a critical forum for leading hematologists/ oncologists to present their findings to over 20,000 of their peers. Among the distinguished scientists attending, more than 50 percent of LRF Scholars — participants in LRF’s Lymphoma Scientific Mentoring Program — presented abstracts at the 2020 ASH Annual Meeting. In addition to LRF’s representation through presentations, more than 40 percent of LRF grantees (including 90 percent of LRF Scholars) were authors on abstracts selected for the annual meeting. LRF is also represented in nearly 600 abstracts through grantees, Lymphoma Rounds Steering Committee members, Mantle Cell Lymphoma Consortium (MCLC) members, and current and past SAB members. The 2020 ASH Annual Meeting also featured 10 abstracts and presentations stemming from LRF-funded research and 15 COVID-19–related research authored by LRFaffiliated scientists.
PULSE | WINTER EDITION 2021
“ The fact that we have nearly 90 percent of LRF’s Scientific Advisory Board members and more than 40 percent of LRF grantees involved in abstracts at the 2020 ASH Meeting speaks to the caliber of LRF’s world-class scientists and research investment,” says Andrew D. Zelenetz, MD, Phd, Chair of the LRF Scientific Advisory Board. “As Chair of the prestigious SAB, I am encouraged and proud of the incredible research presented by the earlycareer scientists we support.” LRF was represented in nearly
600 abstracts
